LTBR and breast carcinoma: This is in line with the poor breast cancer survival observed in this study, due to the BAFFR-mediated activation of the non-canonical pathway contributing to cell survival [31, 32] and the suggested involvement of the TNFR3 signaling in inflammation-induced carcinogenesis [33].